Torasemide but not furosemide improves myocardial remodeling in patients with chronic heart failure

被引:0
|
作者
López, B
Sánchez, E
González, A
Querejeta, R
Larman, M
Querejeta, R
Larman, M
Díez, J
机构
[1] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain
[2] Donostia Univ Hosp, Div Cardiol, San Sebastian, Spain
[3] Guipuzcoa Policlin, San Sebastian, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1604
引用
收藏
页码:342 / 342
页数:1
相关论文
共 50 条
  • [1] Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide
    Kevin T. Stroupe
    Melissa M. Forthofer
    D. Craig Brater
    Michael D. Murray
    PharmacoEconomics, 2000, 17 : 429 - 440
  • [2] Healthcare costs of patients with heart failure treated with torasemide or furosemide
    Stroupe, KT
    Forthofer, MM
    Brater, DC
    Murray, MD
    PHARMACOECONOMICS, 2000, 17 (05) : 429 - 440
  • [3] The Effects of Torasemide on Patients with Chronic Heart Failure
    Alyavi, Bakhrom
    Mukhamedova, Muyassar
    Arnopolskaya, Dina
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2013, 3 (01) : 20 - 22
  • [4] Comparative effects of torasemide and furosemide in rats with heart failure
    Veeraveedu, Punniyakoti T.
    Watanabe, Kenichi
    Ma, Meilei
    Thandavarayan, Rajarajan A.
    Palaniyandi, Suresh S.
    Yamaguchi, Ken'ichi
    Suzuki, Kenji
    Kodama, Makoto
    Aizawa, Yoshifusa
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (03) : 649 - 659
  • [5] Levocarnitine and torasemide combination improved ventricular remodeling in patients with acute exacerbation of chronic heart failure
    Liao, Guangchong
    Aisa, Zulibiya
    Ma, Jing
    Long, Xunhui
    Chen, Jian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 5614 - 5621
  • [6] Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint
    Spannheimer, A
    Goertz, A
    Dreckmann-Behrendt, B
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1998, 52 (07) : 467 - 471
  • [7] Fibronectin as a Marker of Myocardial Remodeling in Patients with Depression and Chronic Heart Failure
    Sikora, A. K.
    Fedorov, S.
    EUROPEAN PSYCHIATRY, 2024, 67 : S370 - S370
  • [8] EFFICACY AND SAFETY OF TORASEMIDE IN PATIENTS WITH CHRONIC HEART-FAILURE
    ACHHAMMER, I
    HACKER, W
    GLOCKE, M
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (1A): : 184 - 187
  • [9] CARDIAC REMODELING AND MYOCARDIAL-CONTRACTILITY IN PATIENTS WITH CONGESTIVE-HEART-FAILURE TREATED WITH FUROSEMIDE AND ENALAPRIL
    BAUR, LHB
    SCHIPPERHEYN, JJ
    BAAN, J
    VANDERLAARSE, A
    VANDERWALL, EE
    VANDIJK, AD
    BUIS, B
    CATS, VM
    BRUSCHKE, AVG
    BASIC RESEARCH IN CARDIOLOGY, 1991, 86 : 157 - 163
  • [10] Endothelin antagonism with bosentan improves myocardial mechanics and ventricular remodeling in rats with chronic heart failure
    Schafhalter-Zoppoth, I
    Teerlink, JR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 171A - 171A